Dietryn 500 Review

Lose Weight Eating Real Food. Not A Crappy Pill

Medifast is backed by science, and is a publicly traded 200+ million dollar company. Check out my review of medifast, click the button below.

 

One of the new-fangled diet supplements that is vying for the attention of weight loss enthusiasts is Dietryn 500. Dietryn 500 is just essentially an appetite suppressant that will help a person lose weight through decreased caloric intake. However, most of the advertisements for the product are making an exaggeration of the actual benefits you can squeeze out of the product.

According to the ads, other than being an appetite suppressant, it is also an effective fat burner because it increases the metabolism faster than any diet pill or tea can do! Unfortunately, this might just be an overstatement as there are only one or two studies that affirm this claim. It is even very difficult to access a drug literature of this pill. The patent pending technology utilized by Dietryn 500 allows weight loss enthusiasts to maintain a limited caloric intake through the upshot of leptin and ghrelin. These are two hormones which are said to control appetite. Compared to standard "diet" products, Dietryn 500 claims to increases mental clarity as well as the length of physical stimulation and appetite suppression, but then again, the mechanism behind this claim is not thoroughly explained making it difficult for us to appreciate these claims.

Dietryn 500 Scam?

One statement from the advertisements that lures consumers is its promise to help you lose weight without changing your lifestyle and diet. Now, we are all aware that such is very impossible unless we are talking here about a “miracle pill” that every dieters would wish exists. To complete the list, the product even claims to help you lose weight in a few minutes after taking it. How can a plain appetite suppressant be an all in one pill in an instant?  Clearly, this is not possible, at all.

It is quite difficult for us not to be skeptical about Dietryn 500 because of its too-good-to-be-true promises that are weakened by lack of adequate information and clinical studies to support them.